Biocardia reports first quarter 2021 financial results and business highlights

San carlos, calif., may 13, 2021 (globe newswire) -- biocardia®, inc. [nasdaq: bcda], a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies, today reported financial results for the first quarter of 2021 and filed its quarterly report on form 10-q for the three months ended march 31, 2021 with the securities and exchange commission on may 13, 2021.
BCDA Ratings Summary
BCDA Quant Ranking